share_log

Amgen Shares Are Trading Lower Following the Results of Its Phase 2 Study With MariTide in Obesity.

Benzinga ·  20:50
Amgen Shares Are Trading Lower Following the Results of Its Phase 2 Study With MariTide in Obesity.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment